Variations of CYP3A activity induced by antiretroviral treatment in HIV-1 infected patients

Jacques Fellay, Amalio Telenti, Thierry Buclin, Laurent Décosterd
2005
Article

Résumé

To measure the in vivo variations of CYP3A activity induced by anti-HIV drugs in human immunodeficiency virus (HIV)1-positive patients

Source officielle

https://infoscience.epfl.ch/record/165065?ln=fr

À propos de ce résultat

Cette page est générée automatiquement et peut contenir des informations qui ne sont pas correctes, complètes, à jour ou pertinentes par rapport à votre recherche. Il en va de même pour toutes les autres pages de ce site. Veillez à vérifier les informations auprès des sources officielles de l'EPFL.

Variations of CYP3A activity induced by antiretroviral treatment in HIV-1 infected patients

Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV: The Swiss HIV Cohort Study

Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 years

Phylogenetic estimation of the viral fitness landscape of HIV-1 set-point viral load

Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 years

Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV: The Swiss HIV Cohort Study

Phylogenetic estimation of the viral fitness landscape of HIV-1 set-point viral load